Moderna Shares Spike 11.7% on H5N1 Vaccine News
Moderna stock jumps 11.7% following potential H5N1 vaccine news amid first U.S. bird-flu fatality, boosting investor confidence.
Topic
H5N1
A collection of 4 issues
Moderna Shares Jump 11.7% Amid Bird-Flu Vaccine Interest
Moderna's stock sees an 11.7% rise as U.S. reports first bird-flu fatality, driving demand for its H5N1 vaccine. Explore the impact on vaccine stocks today.
Company Advances H5N1 Vaccine Development
Explore the company's groundbreaking efforts in developing a vaccine for H5N1. Stay informed with the latest updates on avian influenza research.
Elderly Patient Contracts H5N1 from Birds
A patient over 65 with health issues contracted H5N1 after exposure to backyard flocks and wild birds. Learn more about avian flu risks.